Submission of Letter of Offer for Buy- Back upto 16,00,000 Equity Shares at price of INR-250/- per share amounting to INR-40,00,00,000/-
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jagsonpal Pharmaceuticals Ltd is undertaking a buyback of up to 16 lakh fully paid-up equity shares (2.38% of total paid-up capital) at ₹250 per share via tender offer route through stock exchanges. The total buyback size is ₹40 crore, representing 18.35% of the company's aggregate paid-up capital and free reserves as per FY2025 financials, well within the statutory 25% limit. The record date for determining eligible shareholders is May 04, 2026. The buyback window opens on May 08, 2026 and closes on May 14, 2026, with settlement expected by May 21, 2026. The buyback is being funded from internal accruals and cash balances. Small shareholders holding shares worth up to ₹2 lakh as on record date are reserved a portion of the buyback.
Shareholders can tender their shares at ₹250 per share, receiving cash directly. The buyback will reduce outstanding shares and could support the stock price, though the company deploys ₹40 crore in cash for the program.